Ashkenazi was CFO at Lilly from 2021 until leaving the company this summer. Like Montarce, she joined Lilly in 2001. During ...
Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...
Eli Lilly is planning the expansion of its research centre in India and will be partnering with other Indian companies. Eli ...
The letter is the latest sign that the battle between the brand-name drug manufacturers and the companies that make and sell ...
Eli Lilly's valuation is a critical concern, but its robust execution has improved its ability to actualize its high-growth ...
The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.
On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and children 12 and ...
India is emerging as an economic superpower, highlighted David Ricks, CEO, Eli Lilly, a pharmaceutical company, following a ...
Netflix and Eli Lilly lead this weekend's list of five stocks near buy points that are all enjoying rapid sales growth.